65 I B, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79722D0002
Awardee
Awarding agency
Task orders
25

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 92% complete
IDV ceiling
$700,000.00
Award type
Multiple award
Who can order
All agencies
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

GSA awarded a Federal Supply Schedule contract on November 1, 2021, to Kiniksa Pharmaceuticals (UK), LTD. under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, with a $700,000 ceiling and ultimate completion date of April 30, 2027. This multiple-award schedule vehicle enables federal agencies to procure Arcalyst (rilonacept), a specialty injectable pharmaceutical indicated for treating chronic inflammatory disorders including recurrent pericarditis and cryopyrin-associated periodic syndromes, on an open-competition basis without set-aside restrictions.

Kinikska operates as a foreign-owned biopharmaceutical company specializing in anti-inflammatory therapies and serves exclusively as a prime contractor with no subcontracting footprint. Place of performance spans Great Britain (primary manufacturing) and multiple U.S. locations including Dublin, Ohio; Westworth Village, Texas; Seattle, Washington; Fresno, California; Lexington, Massachusetts; and La Vergne, Tennessee, serving geographically dispersed VA medical facilities and federal correctional institutions.

Under this schedule contract, twenty-six delivery orders totaling approximately $1.7 million in obligated value have been placed since award. Recent notable orders include a $220,229.15 delivery order from Veterans Integrated Service Network 20 in December 2025 for bulk Arcalyst 220 mg vials with 2026 pricing; a $193,121.16 order from VISN 20 in June 2025 supporting VA and Department of Justice Bureau of Prisons supply; a $143,886.87 order from VISN 20 in April 2024 with 2025 price increase; and a $170,125.09 order from VISN 20 in June 2023 for Rilonacept 220 mg/vial injections delivered to Seattle, Washington. Delivery order values typically range from fifteen thousand to two hundred twenty thousand dollars. The contractor also holds a separate $5.9 million single-award Blanket Purchase Agreement with the VA National Acquisition Center under the same schedule, effective through November 2026.

Task orders

Task order Ordering agency Obligated Awarded
Arcalyst 220 MG 36C24526N0731 Veterans Integrated Service Network 5 (VHA) $34,023
Arcalyst 220 MG 36C24526N0595 Veterans Integrated Service Network 5 (VHA) $34,023
Arcalyst 200 MG 36C24526N0418 Veterans Integrated Service Network 5 (VHA) $34,023
Arcalyst 200 MG 36C24526N0294 Veterans Integrated Service Network 5 (VHA) $34,023
Bulk - arcalyst 220MG VIL 36C26026F0076 Veterans Integrated Service Network 20 (VHA) $220,229
Bulk arcalyst 36C26025F0125 Veterans Integrated Service Network 20 (VHA) $193,121
Arcalyst 220MG VIL 36C26025F0112 Veterans Integrated Service Network 20 (VHA) $208,833
Cardinal health, arcalyst 220 MG/VIL INJ, FY24 15B50524F00000177 Federal Medical Center Carswell (BOP) $83,545
Arcalyst rilonacept 36C26124N0718 Veterans Integrated Service Network 21 (VHA) $31,805
Arcalyst (RILONACEPT) 220 MG NDC: 73604-0914-04 36C26124N0682 Veterans Integrated Service Network 21 (VHA) $15,903
Arcalyst (rilonacept ) 220MG 36C26124N0612 Veterans Integrated Service Network 21 (VHA) $15,903
Rilonacept 220MG/VIL INJ 36C26124N0572 Veterans Integrated Service Network 21 (VHA) $15,903
Aralyst 36C26024F0335 Veterans Integrated Service Network 20 (VHA) $143,887
Cardinal health, arcalyst 220 MG/VIL INJ, FY24 15B50524F00000114 Federal Medical Center Carswell (BOP) $41,772
Cardinal health, arcalyst 220MG vial, FY24 15B50524F00000090 Federal Medical Center Carswell (BOP) $41,772
Cardinal health, arcalyst 220MG vial, FY24 15B50524F00000079 Federal Medical Center Carswell (BOP) $81,426
Kiniska phamarceuticals, arcalyst 220 MG/VIL INJ, FY24 15B50524F00000050 Federal Medical Center Carswell (BOP) $0
Cardinal health, arcalyst 220 MG/VIL INJ, FY24 15B50524F00000032 Federal Medical Center Carswell (BOP) $20,180
Rilonacept (ARCALYST) 220MG/VIL INJ 36C26023F0351 Veterans Integrated Service Network 20 (VHA) $170,125
Rilonacept 36C26023F0017 Veterans Integrated Service Network 20 (VHA) $0
Rilonacept (ARCALYST) 220MG/VIL INJ 36C26022F0237 Veterans Integrated Service Network 20 (VHA) $195,452
Arcalyst (RILONACEPT) 220MG/vial injection 36C26022F0186 Veterans Integrated Service Network 20 (VHA) $30,010
Arcalyst (RILONACEPT) 220 MG/vial injection 36C25222F0102 Veterans Integrated Service Network 12 (VHA) $15,005
Arcalyst 36C25222F0067 Veterans Integrated Service Network 12 (VHA) $14,953
Arcalyst 36C25222F0044 Veterans Integrated Service Network 12 (VHA) $14,953
Show all 25

IDV awards

IDV Agency Ceiling Awarded
36E79722A0008 BPA for arcalyst National Acquisition Center (VA) $5,900,000

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00016 · 6-month temporary contract extension $0
Supplemental Agreement for work within scope P00014 · Administrative change to company address and signatory authority form $0
Other Administrative Action P00013 · POC change $0
Supplemental Agreement for work within scope P00012 · 2026 public law pricing update $0
Supplemental Agreement for work within scope P00011 · 2025 small business subcontracting plan $0
Other Administrative Action P00010 · Administrative change to signatory authority form $0
Supplemental Agreement for work within scope P00009 · PL 2025 pricing update $0
Supplemental Agreement for work within scope P00008 · 65IB: administrative changes - signatory authority form update $0
Supplemental Agreement for work within scope P00007 · 42-2A 2024 public law 102-585 pricing update (dual pricing) $0
Other Administrative Action P00006 · 65IB: administrative change alternate point of contact $0
Supplemental Agreement for work within scope P00005 · 42-2A 2023 public law 102-585 pricing update (dual pricing) $0
Supplemental Agreement for work within scope P00004 · 65IB - SIN 42-2A - administrative big 4 price correction $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 · 65IB: administrative changes - contact for contract administration $0
Supplemental Agreement for work within scope P00001 · 42-2A 2022 public law 102-585 pricing update (dual pricing) $0
Original award $0
Show all 16

Quick answers

Who was awarded contract 36F79722D0002?

36F79722D0002 was awarded to Kiniksa Pharmaceuticals (Uk), LTD. by Veterans Integrated Service Network 12 (Veterans Health Administration) on November 1, 2021.

How much is contract 36F79722D0002 worth?

36F79722D0002's own ceiling is $700,000.

How many orders have been placed under contract 36F79722D0002?

25 orders have been placed under 36F79722D0002, the latest on July 13, 2026.

Who can order from contract 36F79722D0002?

36F79722D0002 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79722D0002 part of a contract vehicle?

Yes. 36F79722D0002 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79722D0002 competed?

The extent of competition for 36F79722D0002 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV